Literature DB >> 23843300

Usefulness of time-to-positivity in aerobic and anaerobic vials to predict the presence of Candida glabrata in patients with candidaemia.

Nazaret Cobos-Trigueros1, Laura Morata, Jorge Torres, Yuliya Zboromyrska, Alex Soriano, Cristina Pitart, Cristina De La Calle, Francesc Marco, Cristina Hernandez, Manel Almela, Josep Mensa, Jose Antonio Martinez.   

Abstract

OBJECTIVES: To determine whether time-to-positivity (TTP) in aerobic and anaerobic blood culture vials is useful to predict the presence of Candida glabrata in patients with candidaemia.
METHODS: TTP was recorded for both aerobic and anaerobic vials for each blood culture set of monomicrobial candidaemia. We considered TTP as the shortest time registered for any positive vial. Two diagnostic criteria were evaluated: the cut-off TTP value as obtained from a receiver operating characteristic curve and the detection of growth only or with a shorter TTP in anaerobic vials.
RESULTS: A total of 157 episodes were analysed of which 19 (12.1%) were due to C. glabrata. The TTP for C. glabrata was longer than that for other species. C. glabrata grew more frequently than other species in anaerobic vials [9/19 (47%) versus 19/138 (14%); P = 0.001] and also more often exclusively or earlier in anaerobic vials [7/19 (37%) versus 5/138 (4%); P < 0.0001]. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of a TTP >56.5 h for predicting the presence of C. glabrata were 47%, 88%, 36% and 92%, respectively. Growth detection only or earlier in anaerobic flasks had a sensitivity of 37%, a specificity of 96%, a PPV of 58% and an NPV of 92%.
CONCLUSIONS: Using the BACTEC 9240 system, a TTP ≤ 56.5 h is useful to rule out C. glabrata. In addition, in settings with an ~12% prevalence of C. glabrata candidaemia, yeast detection exclusively or earlier in anaerobic vials increases the probability of the presence of C. glabrata to 58%, which may be useful for early treatment optimization.

Entities:  

Keywords:  bloodstream infections; culture media; time to blood culture positivity

Mesh:

Year:  2013        PMID: 23843300     DOI: 10.1093/jac/dkt285

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Time to positivity and detection of growth in anaerobic blood culture vials predict the presence of Candida glabrata in candidemia: a two-center European cohort study.

Authors:  Nazaret Cobos-Trigueros; Achim J Kaasch; Alex Soriano; Jorge-Luis Torres; Andrea Vergara; Laura Morata; Yuliya Zboromyrska; Cristina De La Calle; Izaskun Alejo; Cristina Hernández; Celia Cardozo; Franscesc Marco; Ana Del Río; Manel Almela; Josep Mensa; José Antonio Martínez
Journal:  J Clin Microbiol       Date:  2014-06-04       Impact factor: 5.948

2.  Impact of systemic antifungal therapy on the detection of Candida species in blood cultures in clinical cases of candidemia.

Authors:  S Bailly; C Garnaud; M Cornet; P Pavese; R Hamidfar-Roy; L Foroni; S Boisset; J-F Timsit; D Maubon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-02       Impact factor: 3.267

3.  Time to positive culture can differentiate post-neurosurgical coagulase-negative Staphylococci other than S epidermidis meningitis from contamination: A case-control observational study.

Authors:  Guanghui Zheng; Siwen Li; Minghui Zhao; Xinrui Yang; Yumeng Zhang; Jia Deng; Yu Luo; Hong Lv; Guojun Zhang
Journal:  J Clin Lab Anal       Date:  2020-07-07       Impact factor: 2.352

4.  Time to Positivity Facilitates an Early Differential Diagnosis of Candida tropicalis from Other Candida species.

Authors:  Xianggui Yang; Mingquan Liu; Xuejing Yu; Zhenguo Wang; Ying Xu
Journal:  Infect Drug Resist       Date:  2022-10-10       Impact factor: 4.177

5.  Evaluation of blood culture media for the detection of fungi.

Authors:  U Nawrot; B Kowalska-Krochmal; B Sulik-Tyszka; M Kozak; K Świętek; M Pajączkowska; E Piątkowska; D Rosiak; E Swoboda-Kopeć
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-08       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.